AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma

Por Schmitz, KJ, Lang, H, Wohlschlaeger, J, Sotiropoulos, GC, Reis, H, Schmid, KW, Baba, HA
Publicado no World J Gastroenterol (2007)

Overexpression of cyclo‐oxygenase‐2 is an independent predictor of unfavourable outcome in node‐negative breast cancer, but is not associated with protein kinase B (Akt) and mitoge...

Por Schmitz, K J, Callies, R, Wohlschlaeger, J, Kimmig, R, Otterbach, F, Bohr, J, Lee, H‐S, Takeda, A, Schmid, K W
Publicado em 2006

MDM2 is an important prognostic and predictive factor for platin–pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to cont...

Por Walter, R F H, Mairinger, F D, Ting, S, Vollbrecht, C, Mairinger, T, Theegarten, D, Christoph, D C, Schmid, K W, Wohlschlaeger, J
Publicado no Br J Cancer (2015)

Loss of Survivin influences liver regeneration and is associated with impaired Aurora B function

Por Hagemann, S, Wohlschlaeger, J, Bertram, S, Levkau, B, Musacchio, A, Conway, E M, Moellmann, D, Kneiseler, G, Pless-Petig, G, Lorenz, K, Sitek, B, Baba, H A
Publicado em 2013

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

Por Christoph, D C, Kasper, S, Gauler, T C, Loesch, C, Engelhard, M, Theegarten, D, Poettgen, C, Hepp, R, Peglow, A, Loewendick, H, Welter, S, Stamatis, G, Hirsch, F R, Schuler, M, Eberhardt, W E E, Wohlschlaeger, J
Publicado em 2012